Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole.
Koener
Beryl
B
Hermans
Emmanuel
E
Emmanuel
Hermans
H
Maloteaux
Jean-Marie
JM
Jean-Jean
Anne
A
Constant
Eric Louis
EL
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D000068180:Aripiprazole; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology; D065127:Dopamine D2 Receptor Antagonists; D005260:Female; D006801:Humans; D008875:Middle Aged; D020734:Parkinsonian Disorders / Q000139:chemically induced*; D010879:Piperazines / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D015363:Quinolones / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D017448:Receptors, Dopamine D2 / Q000819:agonists / Q000187:drug effects
D014150:Antipsychotic Agents; D065127:Dopamine D2 Receptor Antagonists; D010879:Piperazines; D015363:Quinolones; D017448:Receptors, Dopamine D2; D000068180:Aripiprazole